Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter
email:    

Investor News

Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings

Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions
Start-Ups

IPO News
IPO


Biotech/Pharma - Investor
Orexo AB (ORXOF) Has Successfully Completed Its Private Placement Of Approx. SEK 346.5 Million 8/29/2014 11:36:57 AM
ThromboGenics NV (TBGNF) Business Update H1 2014 8/27/2014 11:19:10 AM
Allenex AB: Sales +15% Jan-Jun 2014 8/28/2014 1:10:12 PM
Advanced Cell Technology Announces 1:100 Reverse Stock Split 8/28/2014 12:22:57 PM
Allergan Inc. (AGN) To Request California Federal Court Block Valeant Pharmaceuticals International (VRX) And Pershing Square From Voting Shares Acquired In Violation Of Insider Trading Laws 8/27/2014 9:51:47 AM
BioDelivery Sciences International (BDSI) To Host Investor And Analyst Event And Webcast Friday, September 5 On BUNAVAILâ„¢ Launch And Pipeline 8/27/2014 8:32:40 AM
Transcat, Inc. (TRNS) Increases Secured Revolving Credit Facility 8/27/2014 8:27:19 AM
Sinovac Biotech Ltd. (SVA) Announces Results Of 2014 Annual General Meeting Of Shareholders 8/27/2014 7:51:30 AM
NeuroSigma, Inc. Files Registration Statement for Proposed Initial Public Offering 8/27/2014 7:48:43 AM
Facing Shareholder Demands, Allergan Inc. (AGN) Reluctantly Sets A Date For Special Meeting 8/27/2014 6:08:18 AM
Move Over San Francisco: Boston Showing Its Pharmaceutical Potential 8/21/2014 4:25:47 PM
Wound Management Technologies, Inc. Announces Its 2014 Annual Meeting Of Shareholders 8/26/2014 1:17:14 PM
Viropro Inc. (VPRO) Initiates Interim Debt Financing Of Up To $500,000 8/26/2014 9:34:19 AM
Mesoblast Limited (MSB.AX) Unveils Path To Bring Its Key Products To Market 8/26/2014 7:44:01 AM
Lemelson Capital Comments On Large Institutional Selling In Shares Of Ligand Pharmaceuticals Inc. (LGND) Amidst Company's Insolvency And Mounting Going Concern Risk 8/25/2014 1:41:38 PM
1234567
//-->